-

Exactech Announces Full Launch of its Truliant® Porous Knee System

Porous Technology Expands Options for Patients, Broadens Knee Replacement Offerings for Surgeons

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, today announced the expansion of its Truliant® Total Knee System with a new porous-coated implant option. Full launch of the Truliant Porous Knee is welcome news for surgeons who are interested in a non-cemented approach. It enhances the award-winning knee system and is designed for strength and stability for patients, and efficiency for surgeons and staff in the operating room.

“Exactech’s Truliant Porous Knee embodies state-of-the-art technology, manufacturing and instrumentation allowing surgeons to confidently address our ever-changing patient populations,” said James B. Duke, MD, of the Orthopaedic Institute in Ocala, Fla. “I believe surgeons looking to maximize longevity, performance and durability in their implants will want to utilize Exactech’s Truliant Porous Knee technology to best handle surgical challenges and patient expectations.”

The Truliant Porous Knee enhances the company’s advanced material science platform with a solution that is designed to mimic the trabecular nature of cancellous bone with optimal pore size and porosity. The porous structures integrated into the implant design are designed to facilitate a durable bonding surface to allow for immediate and long-term biological fixation. Peripheral pegs allow for stable initial fixation while the channeled keel is designed with flutes to increase bony-implant engagement for increased stability and resistance to micromotion.

The Truliant Porous Knee seamlessly integrates with the system’s ergonomically designed mechanical instrumentation and the ExactechGPS® TKA Pro application for a guided, personalized experience. The Truliant Total Knee System includes cruciate-retaining and posterior-stabilized implants, as well as constrained insert options, and integrates with a fully comprehensive revision system that offers metaphyseal cones, stems, tibial augments and offsets.

The Truliant Porous Knee is fully available in the US. For more information about Truliant Porous, visit www.exac.com/porous.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, VuMedi, YouTube and Instagram.

Contacts

Priscilla Bennett, APR
VP, Corporate Marketing & Communications
(352) 377-1140

Exactech

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI

Release Summary
Exactech announced today the expansion of its Truliant® Total Knee System with a new porous-coated implant option.
Release Versions

Contacts

Priscilla Bennett, APR
VP, Corporate Marketing & Communications
(352) 377-1140

More News From Exactech

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe. “We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innov...
Back to Newsroom